← FDA DRUG APPROVALS

FDA ANDA · ANDA076355

ALBUTEROL SULFATE

Sponsor: NEPHRON

APPLICATION
ANDA076355
TYPE
ANDA
ORIGINAL APPROVAL
2004-06-28
LATEST ACTION
2011-09-13
ROUTE
RESPIRATORY (INHALATION), INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

ALBUTEROL SULFATEPrescription
ALBUTEROL SULFATE EQ 0.042% BASE · SOLUTION · INHALATION
ALBUTEROL SULFATEPrescription
ALBUTEROL SULFATE EQ 0.021% BASE · SOLUTION · INHALATION

Approval history

2011-09-13Labeling · Supplement 12AP
2010-03-31Labeling · Supplement 7AP
2007-03-29Labeling · Supplement 4AP
2005-03-22Labeling · Supplement 1AP
2004-06-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →